Sector dividends Intellia Therapeutics, Inc.
Equities
NTLA
US45826J1051
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.94 USD | +1.08% |
|
+7.71% | +66.18% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -4.2x | 3.94x | 25.62x | -3.42x | -3.38x | 1.76B | ||
| 1.01% | 1.16% | 32.52x | 3.84x | 5.67x | 17.57x | 24.8x | 47.73B | ||
| -.--% | -.--% | 57.83x | 7.44x | 5.02x | 33.69x | 42.48x | 35.48B | ||
| -.--% | -.--% | 21.92x | 3.96x | 2.49x | 10.72x | 16.33x | 29.9B | ||
| -.--% | -.--% | -19.65x | 28.5x | 517.75x | -18x | -17.92x | 30.23B | ||
| 0.37% | 0.36% | 33.67x | 2.44x | 8.29x | 21.31x | 25.65x | 28.75B | ||
| -.--% | -.--% | 48.72x | 165.12x | 8.71x | 26.25x | 36.18x | 14.93B | ||
| -.--% | -.--% | 30.3x | 15.43x | 4.92x | 22.38x | 23.44x | 14.81B | ||
| 1.08% | 1.25% | 23.4x | 2.56x | 2.04x | 8.92x | 13.92x | 14.42B | ||
| -.--% | -.--% | -18.78x | -52.26x | 14.86x | -20.55x | -19.11x | 12.69B | ||
| -.--% | -.--% | -29.05x | 38.3x | 2965.14x | -32.49x | -29.04x | 9.68B | ||
| -.--% | -.--% | -22.69x | 8.42x | 1396.29x | -19.18x | -18.96x | 9.47B | ||
| 0.55% | 0.55% | 46.54x | 4.23x | 7.45x | 20.86x | 22.94x | 9.15B | ||
| -.--% | -.--% | -33.88x | 23.81x | 6.74x | 167.71x | -318.04x | 10.11B | ||
| -.--% | -.--% | 26.45x | 2.61x | 2.74x | 10.76x | 13.08x | 8.91B | ||
| 0.32% | 0.46% | 18.79x | 2.27x | 4.15x | 11.17x | 14.07x | 8.61B | ||
| -.--% | -.--% | 18.06x | 0.96x | 1.46x | 7.48x | 8.27x | 8.9B | ||
| 0.82% | 0.97% | 27.42x | 3.21x | 3.41x | 14.13x | 20.69x | 7.75B | ||
| Average | 0.23% | 0.26% | 14.30x | 14.71x | 276.82x | 15.52x | -8.03x | 16.85B | |
| Weighted average by Cap. | 0.29% | 0.33% | 20.64x | 14.44x | 194.69x | 15.72x | 4.02x |
- Stock Market
- Equities
- NTLA Stock
- Sector Intellia Therapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















